Skyrizi was the top Rx and over-the-counter (OTC) pharma brand advertising on TV in 2024, according to data released by iSpot.tv on Thursday afternoon. AbbVie’s psoriasis, ulcerative colitis, Crohn’s ...
Physicians have delivered a boost to AbbVie’s hopes of turning Skyrizi into a $17-billion-a-year drug. The 101 gastroenterologists polled by Spherix Global Insights talked up Skyrizi’s promise in ...
Zacks Investment Research on MSN
Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?
AbbVie ABBV remains a dominant force in the immunology space, powered by the continued uptake of its two blockbuster ...
AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April, according to data released by iSpot.tv on Wednesday afternoon. The psoriasis treatment garnered an impressions ...
It was déjà vu all over again for TV drug ad spending in August, as the top 10 spenders barely deviated from July’s list and turned in a combined total nearly identical to the preceding month’s haul.
“AbbVie continues to perform exceptionally well,” Richard Gonzalez, chairman and chief executive officer, told analysts Friday as he kicked off the pharma company’s third quarter earnings call. Even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback